Red Light Photobiomodulation and Topical Disinfectants

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

January 10, 2023

Primary Completion Date

February 8, 2023

Study Completion Date

February 8, 2023

Conditions
Healthcare Associated InfectionNosocomial InfectionSurgical Site Infection
Interventions
DEVICE

Methylene Blue Only

"All subjects will have a baseline sample taken of their nasal microbiome and undergo the administration of the following:~\- Methylene Blue (0.01%) + 4 minutes of light treatment"

DEVICE

Chlorhexidine Gluconate Only

"All subjects will have a baseline sample taken of their nasal microbiome and undergo the administration of the following:~\- Chlorhexidine gluconate (0.25%) + 4 minutes of light treatment"

DEVICE

Methylene Blue + Chlorhexidine Gluconate

"All subjects will have a baseline sample taken of their nasal microbiome and undergo the administration of the following:~\- Methylene blue (0.01%) + chlorhexidine gluconate (0.25%) + 4 minutes of light treatment"

DEVICE

Light Only

"All subjects will have a baseline sample taken of their nasal microbiome and undergo the administration of the following:~\- 4 minutes of light treatment only"

Trial Locations (1)

98011

Ondine Research Laboratories, Bothell

Sponsors
All Listed Sponsors
lead

Ondine Biomedical Inc.

INDUSTRY